Status:
COMPLETED
What Are the Determinant Factors of Ceasing Anti-seizure Medication in Infants With Neonatal Seizures?
Lead Sponsor:
Balikesir University
Conditions:
Neonatal Seizure
Eligibility:
All Genders
1-2 years
Brief Summary
The investigators aimed to determine the factors for ceasing anti-seizure medication in infants who experienced seizures during the neonatal period. This retrospective, single-center, descriptive stud...
Detailed Description
This retrospective, single-center, descriptive study was conducted at the Department of Paediatric Neurology between December 2020 and February 2023, and 157 neonates were recruited to determine the f...
Eligibility Criteria
Inclusion
- Neonates with seizures diagnosed clinically or with conventional electroencephalography (cEEG) confirmation were enrolled.
Exclusion
- with abnormal paroxysmal events that weren't determined to be seizures by cEEG, amplitude integrated EEG (aEEG) and video records,
- stopped medications due to their parents' decisions,
- with missing hospital records,
- delivered from pregnancies by assisted reproductive techniques were not enrolled.
Key Trial Info
Start Date :
January 1 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
October 1 2023
Estimated Enrollment :
158 Patients enrolled
Trial Details
Trial ID
NCT06211192
Start Date
January 1 2020
End Date
October 1 2023
Last Update
January 18 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Orkun Çetin
Balıkesir, Altieylul, Turkey (Türkiye), 10100